Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Beimao is a specialized pharmaceutical marketing and distribution company operating as a key subsidiary of the China Resources Pharmaceutical Group. Based in Beijing, the company focuses on the commercialization of high-end specialized therapeutics, particularly in the fields of reproductive health, pediatric growth hormones, and orphan drugs for rare diseases. It serves as a critical strategic partner for multinational pharmaceutical companies, such as Merck KGaA, facilitating the entry and expansion of innovative biological products into the Chinese market. The company is recognized for its expertise in academic promotion and its robust cold-chain logistics capabilities for sensitive biological products. By focusing on niche therapeutic areas, China Resources Beimao has established a leading market position in growth disorders and assisted reproductive technology across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Beimao.